These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
26. [Critical analysis of drug policy in Brazil]. Zepeda Bermúdez JA; de Albuquerque Possas C Bol Oficina Sanit Panam; 1995 Sep; 119(3):270-7. PubMed ID: 7576188 [No Abstract] [Full Text] [Related]
27. [New pharmaceutical legislation in Italy and Federal Republic of Germany in relation to European Economic Community directives]. Cavatorta L Boll Chim Farm; 1979 Mar; 118(3):144-62. PubMed ID: 475906 [No Abstract] [Full Text] [Related]
28. [Large scale "monitoring" for drug safety]. Ghione M Boll Chim Farm; 1971 Oct; 110(10):573-8. PubMed ID: 5143355 [No Abstract] [Full Text] [Related]
29. [Standards imposed by the pharmacopoeia on drugs]. Büchi J Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534 [No Abstract] [Full Text] [Related]
30. Counterfeiting and piracy of pharmaceuticals. Grackin A IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698 [No Abstract] [Full Text] [Related]
31. [Official inspections of a pharmaceutical plant during the registration of new products]. De Martiis F; Fontani F; Zanotti-Gerosa A Boll Chim Farm; 1982 Jul; 121(7):319-27. PubMed ID: 7150440 [No Abstract] [Full Text] [Related]
32. [Guidelines for the certification of drug preparations according to the proposed new drug law]. Rieger HJ Dtsch Med Wochenschr; 1976 Feb; 101(7):260-2. PubMed ID: 1248410 [No Abstract] [Full Text] [Related]
33. QUAD routes out inferior drugs. Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804 [No Abstract] [Full Text] [Related]
34. WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445 [TBL] [Abstract][Full Text] [Related]
35. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices. Moken MC Am J Law Med; 2003; 29(4):525-42. PubMed ID: 15119247 [No Abstract] [Full Text] [Related]
37. 3. Drug regulations in Switzerland and their application. Hippenmeier F Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448 [No Abstract] [Full Text] [Related]
38. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report. WHO Expert Committee on Specifications for Pharmaceutical Preparations World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287 [TBL] [Abstract][Full Text] [Related]
39. Italian health sector in disarray following more scandals. Abbott A Nature; 1993 Aug; 364(6439):663. PubMed ID: 8355773 [No Abstract] [Full Text] [Related]
40. [Importance of patents for the qualitative level in the evaluation of drugs]. Rovati AL Boll Chim Farm; 1971 Oct; 110(10):569-72. PubMed ID: 5143354 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]